Cholesgen Pharmaceutical
PrivateLast Round
Series A
Extension
Feb 21, 2025
Total Funding Raised
$28M
Company Overview
Cholesgen Pharmaceutical is a biopharmaceutical company that develops innovative drugs for metabolic diseases, such as hyperlipidemia, obesity, diabetes, atherosclerosis, and NASH, as well as oncology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cholesgen Pharmaceutical Comparables
Compare Cholesgen Pharmaceutical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rona Therapeutics | 78% | |
| MindRank | 77% | |
| Lime Therapeutics | 74% | |
Cholesgen Pharmaceutical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Feb 21, 2025 | ||||
| Series A | May 30, 2023 | ||||
| Angel | Apr 1, 2021 |
Cholesgen Pharmaceutical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CICC Capital | Series A |
| Trinity Innovation Fund | Series A, Angel |
| SDIC Venture Capital | Series A Extension |
| Gaorong Capital | Series A |
| Trinity Innovation Fund | Angel, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 21, 2025
$14M round led by SDIC Venture Capital
- Apr 1, 2021
Trinity Innovation Fund led the round.
Cholesgen Pharmaceutical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cholesgen Pharmaceutical's valuation, stock price, and market status.